ERIS Lifesciences Ltd Financials Statements

    Annual and Quarterly P/L, Balance Sheet, Cash Flow & Financial Ratios

    Consolidate
    Standalone
    Financial Year
    Mar '25
    Dec '24
    Sep '24
    Jun '24
    Mar '24
    Total Qtr Revenue cr
    713.25
    731.67
    745.72
    721.36
    566.07
    Other Income Qtr Cr7.954.226.771.6415.15
    Operating Revenues Qtr705.30727.45738.95719.72550.92

    *All values are in Cr.

    Operating Expenses Qtr
    452.91
    477.14
    476.66
    469.73
    402.49
    Operating Profit Qtr
    252.39
    250.31
    262.29
    249.99
    148.43
    EBITDA Qtr Cr
    260.34
    254.53
    269.06
    251.63
    163.58
    Depreciation Qtr
    77.25
    81.20
    80.48
    75.94
    53.90
    Net Profit Qtr
    93.84
    83.63
    91.59
    83.18
    70.96
    Basic EPS Qtr
    6.90
    6.15
    6.73
    6.11
    5.22
    Open Demat Account
    +91 -

    Open Demat Account
    +91 -